The urotensin system is up-regulated in the pre-hypertensive spontaneously hypertensive rat

PloS One
Ellen J Forty, Nick Ashton

Abstract

Urotensin II (UII) concentrations are raised both in humans with hypertension and in spontaneously hypertensive rats (SHR). Since the urotensin system acts to regulate glomerular filtration in the kidney it may play a greater role in the pre-hypertensive SHR in which renal dysfunction is known to precede the onset of severe hypertension. This study aimed to determine the renal actions and expression of the urotensin system in the young SHR. Intravenous rat UII (6 pmol. min(-1). 100 g body weight(-1)) had no significant effect on GFR; however urotensin-related peptide (URP) reduced GFR (P<0.05) in 4-5 week old SHR. Administration of the UT antagonist SB-706375 evoked marked increases in GFR (baseline 0.38 ± 0.07 vs antagonist 0.76 ± 0.05 ml. min(-1). 100 g body weight(-1), P<0.05), urine flow and sodium excretion (baseline 2.5 ± 0.4 vs antagonist 9.1 ± 2.1 µmol. min(-1). 100 g body weight(-1), P<0.05) in the SHR. Normotensive Wistar-Kyoto rats showed little response to UT antagonism. Quantitative RT-PCR showed that neither UII nor UT mRNA expression differed between the kidneys of young SHR and WKY rats; however expression of URP was 4-fold higher in the SHR kidney. Renal transcriptional up-regulation indicates that URP is the m...Continue Reading

References

Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·C J Chen, M F Lokhandwala
Nov 1, 1982·Hypertension·W H BeierwaltesP J Klemmer
Jan 1, 1995·Journal of Cardiovascular Pharmacology·R M TouyzE L Schiffrin
Jun 26, 2001·Clinical and Experimental Pharmacology & Physiology·I Gouldsborough, N Ashton
Oct 11, 2003·Biochemical and Biophysical Research Communications·Tsukasa SugoMasahiko Fujino
Apr 23, 2004·Trends in Pharmacological Sciences·Stephen A DouglasDouglas G Johns
Jun 18, 2004·Journal of Hypertension·Bernard M Y CheungLouisa Y F Wong
Nov 24, 2004·Clinical and Experimental Hypertension : CHE·Gabrielle GendronDomenico Regoli
Apr 27, 2005·British Journal of Pharmacology·Stephen A DouglasDashyant Dhanak
Mar 15, 2006·Kidney International·W SongN Ashton
Jan 31, 2007·American Journal of Hypertension·Toshiaki SuguroMitsuru Adachi
Dec 19, 2007·Hypertension·Carmine ZoccaliLorenzo Malatino
Feb 16, 2008·Current Opinion in Nephrology and Hypertension·Carmine ZoccaliFrancesca Mallamaci
Jun 26, 2008·The Journal of Endocrinology·Alaa E S Abdel-RazikNick Ashton
Aug 15, 2008·American Journal of Physiology. Renal Physiology·Alaa E S Abdel-RazikNick Ashton
Jul 14, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ari MosenkisRaymond R Townsend
Feb 14, 2012·Experimental Physiology·Ellen J Forty, Nick Ashton

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collection
PCR

Software Mentioned

geNorm
Primer Design
SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.